Assignee
VERSEAU THERAPEUTICS INC
US·1 granted patent·6 pending applications·0 citations·filing 2019–2021
Top patents by PatentIndex Score
7 records- 0144US2021317461A1Oligonucleotide compositions for targeting ccr2 and csf1r and uses thereofVERSEAU THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 0238US2023348603A1Anti-vsig4 compositions and methods for modulating myeloid cell inflammatory phenotypes and uses thereofVERSEAU THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0336US2022363752A1Anti-lrrc25 compositions and methods for modulating myeloid cell inflammatory phenotypes and uses thereofVERSEAU THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 0436US2022251233A1Anti-cd53 compositions and methods for modulating myeloid cell inflammatory phenotypes and uses thereofVERSEAU THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 0535US12552873B2Anti-PSGL-1 compositions and methods for modulating myeloid cell inflammatory phenotypes and uses thereofVERSEAU THERAPEUTICS INC·Filed 2020·Granted Feb 17, 2026·0 cites·29 claims
- 0634US2021189342A1Compositions and methods for modulating monocyte and macrophage inflammatory phenotypes and immunotherapy uses thereofVERSEAU THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 0734US2022396627A1Anti-siglec-9 compositions and methods for modulating myeloid cell inflammatory phenotypes and uses thereofVERSEAU THERAPEUTICS INC·Filed 2020·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →